Adamas Pharma Balance Sheet - Quarterly (NASDAQ:ADMS)

Add to My Stocks
$25.27 $0.53 (2.05%) ADMS stock closing price Jun 19, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Adamas Pharma, and helps in stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Adamas Pharma stock analysis. A company releases its balance sheet every quarter along with its quarterly results. Adamas Pharma balance sheet as at the end of 2018 Q1 indicates an asset turnover ratio of and debt to equity ratio of . Also check Adamas Pharma revenue and Adamas Pharma operating cash flow for the same period.

View and download Adamas Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Marketable Securities147.58M82.12M101.6M94.72M91.15M89.91M92.4M46.85M64.87M73.69M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets3.49M3.66M2.8M1.81M1.47M2.54M7.43M6.33M5.83M5.1M
Total Current Assets
Property Plant & Equipment-5.65M---4.49M---2.97M
Accumulated Depreciation-2.52M---1.33M----
Net Property Plant & Equipment
Investment & Advances88.12M2.99M7M16.58M10.08M22.29M43.72M1.9M5.92M13.16M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable-----4M----
Accounts Payable8.13M3.87M5.38M4.38M3.01M3.58M5.95M4.72M3.5M3.05M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses12.35M12.38M9.53M6.39M4.93M5.86M6.3M7.84M6.88M8.45M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt107.1M102.64M35.4M33.76M------
Non-Current Capital Leases----------
Other Long-Term Liabilities---1.2M------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus416.6M277.96M268.3M263.04M258.12M254.55M251.35M247.95M243.04M178.47M
Retained Earnings-246.67M-211.69M-182.34M-158.98M-138.23M-122.2M-107.24M-92.85M-75.97M-62.15M
Treasury Stock----------
Other Liabilities-0.36M-0.16M-0.11M-0.18M-0.16M-0.19M-0.06M---0.15M
Shareholders Equity169.6M66.12M85.87M103.9M119.74M132.18M144.06M155.16M167.1M116.18M
Total Liabilities & Shareholders Equity298.38M186.17M137.11M149.92M128.49M142.47M157.22M168.64M178.45M128.74M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Adamas Pharma historical stock prices and the current Adamas Pharma stock price can tell you how the stock price has moved, whereas the Adamas Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Adamas Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for ADMS stock as of 2018 Q1 is $298.38M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Adamas Pharma is $128.78M. Shareholders equity comes under liabilities as it is money the company owes the holders of ADMS stock.

Adamas Pharma Balance Sheet - Key Ratios

Price to book ratio